A protein profile study to discriminate CIN lesions from normal cervical epithelium

Cellular Oncology

Volumn 34, Issue 5, 2011, Pages 443-450

  Uleberg, Kai Erik ^a,b,c   Munk, Ane Cecilie ^a   Skaland, Ivar ^a   Furlan, Cristina ^a   Van Diermen, Bianca ^a   Gudlaugsson, Einar ^a,c   Janssen, Emiel A M ^a   Malpica, Anais ^d   Feng, Weiwei ^e   Hjelle, Anne ^b   Baak, Jan P A ^a,c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b INTERNATIONAL RESEARCH INSTITUTE OF STAVANGER   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF TEXAS   (United States)

^e FUDAN UNIVERSITY   (China)

Author keywords

Cervical intraepithelial neoplasia; CIN; Mass spectrometry; Proteomics; SELDI TOF

Indexed keywords

KI 67 ANTIGEN; PROTEIN; PROTEIN P16; UNCLASSIFIED DRUG; WATER SOLUBLE PROTEIN; TUMOR PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; INCUBATION TEMPERATURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PUNCH BIOPSY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; BIOPSY; CHEMISTRY; CONFIDENCE INTERVAL; EPITHELIUM; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROTEOMICS; UTERINE CERVIX;

ADULT; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CONFIDENCE INTERVALS; EPITHELIUM; FEMALE; HUMANS; NEOPLASM PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84860585342     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0047-3     Document Type: Article

References (34)

1. A.E. Pollack, M.S. Balkin, L. Denny, Cervical cancer: a call for political will. Int. J. Gynaecol. Obstet. 94(3), 333-342 (2006)
2. J.M. Walboomers, M.V. Jacobs, M.M. Manos et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189(1), 12-19 (1999)
3. R.P. Insinga, E.J. Dasbach, E.H. Elbasha, Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect. Dis. 9, 119 (2009)
4. J.P.A. Baak, A.J. Kruse, S.J. Robboy et al., Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J. Clin. Pathol. 59(10), 1017-1028 (2006)
5. P. Martin-Hirsch, E. Paraskevaidis, H. Kitchener et al., Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst. Rev. 2, CD001318 (2000)
6. A.G. Ostor, Natural-history of cervical intraepithelial neoplasia -a critical review. Intern J Gynl Pathol 12(2), 186-192 (1993)
7. J.P.A. Baak, A.J. Kruse, Use of biomarkers in the evaluation of CIN grade and progression of early CIN. Meth. Mol. Med. 119, 85-99 (2005)
8. M.F. Addis, A. Tanca, D. Pagnozzi et al., Generation of highquality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 9(15), 3815-3823 (2009)
9. M.F. Addis, A. Tanca, D. Pagnozzi et al., 2-D PAGE and MS analysis of proteins from formalin-fixed, paraffin-embedded tissues. Proteomics 9(18), 4329-4339 (2009)
10. B.L. Hood, M.M. Darfler, T.G. Guiel et al., Proteomic analysis of formalin-fixed prostate cancer tissue. Mol. Cell. Proteomics 4(11), 1741-1753 (2005)
11. B.L. Hood, T.P. Conrads, T.D. Veenstra, Unravelling the proteome of formalin-fixed paraffin-embedded tissue. Brief Funct Genomic Proteomic 5(2), 169-175 (2006)
12. P.E. Castle, T.M. Phillips, A. Hildesheim et al., Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography. Cancer Epidemiol. Biomark. Prev. 12(12), 1449-1456 (2003)
13. S.H. Song, J.K. Lee, O.S. Seok et al., The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix. Gynecol. Oncol. 104(3), 732-738 (2007)
14. M.Y. Tjiong, N. van der Vange, J.S. ter Schegget et al., Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine 14(6), 357-360 (2001)
15. P.E. Castle, A. Hildesheim, F.P. Bowman et al., Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J. Clin. Immunol. 22(1), 23-27 (2002)
16. M.Y. Tjiong, N. van der Vange, F.J.W. ten Kate, et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. 285-291 (1999)
17. J.A. Lieberman, A.B. Moscicki, J.L. Sumerel et al., Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates. Clin Vacc Immun 15(1), 49-54 (2008)
18. K.K. Azar, M. Tani, H. Yasuda et al., Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum. Pathol. 35(11), 1376-1384 (2004)
19. E.F. Petricoin, L.A. Liotta, SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 15(1), 24-30 (2004)
20. E.F. Petricoin, D.K. Ornstein, L.A. Liotta, Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. Urol. Oncol. 22(4), 322-328 (2004)
21. J.E. Celis, P. Gromov, T. Cabezòn et al., Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment. Mol. Cell. Proteomics 3, 327-344 (2004)
22. H.J. Issaq, T.P. Conrads, D.A. Prieto et al., SELDI-TOF MS for diagnostic proteomics. Anal. Chem. 75(7), 148A-155A (2003)
23. C.P. Paweletz, L.A. Liotta, E.F. Petricoin 3rd, New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Urology 57(4 Suppl 1), 160-163 (2001)
24. K.D. Rodland, Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin. Biochem. 37(7), 579-583 (2004)
25. C. Jansen, K.M. Hebeda, M. Linkels et al., Protein profiling of Bcell lymphomas using tissue biopsies: a potential tool for small samples in pathology. Cell. Oncol. 30, 27-38 (2008)
26. Y.F. Wong, T.H. Cheung, K.W. Lo et al., Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix. Cancer Lett. 211(2), 227-234 (2004)
27. C.J. Piyathilake, D.K. Oelschlager, S. Meleth et al., Plasma protein profiles differ between women diagnosed with cervical intraepithelial neoplasia (CIN) 1 and 3. Cancer Inf. 2, 345-349 (2007)
28. G. Panicker, D.R. Lee, E.R. Unger, Optimization of SELDI-TOF protein profiling for analysis of cervical mucous. J. Proteomics 71 (6), 637-646 (2009)
29. M. Dijkstra, R.J. Vonk, R.C. Jansen, SELDI-TOF mass spectra: a review on sources of variation. J. Chromatogr. B 847, 12-23 (2007)
30. M. De Bock, D. de Seny, M.-A. Meuwis et al., Challenges for biomarker discovery in body fluids using SELDI-TOF MS. J. Biomed. Biotechnol. 2010, 906082 (2009)
31. J.P.A. Baak, The framework of pathology: good laboratory practice by quantitative and molecular methods. J. Pathol. 198, 277-283 (2002)
32. H.J. Issaq, K.C. Chan, G.M. Janini et al., Multidimensional separation of peptides for effective proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci 817(1), 35-47 (2005)
33. W.H. McDonald, R. Ohi, D.T. Miyamoto et al., Comparison of three directly coupled HPLC MS/MS strategies for identification of proteins from complex mixtures: single-dimension LC-MS/MS, 2-phase MudPIT, and 3-phase MudPIT. Int. J. Mass Spectrom. 219(1), 245-251 (2002)
34. A. Gorg, W. Weiss, M.J. Dunn, Current two-dimensional electrophoresis technology for proteomics. Proteomics 4(12), 3665-3685 (2004)